Cohera Announces Treatment of 1st Patient in U.S. Clinical Study of TissuGlu® Surgical Adhesive

Cohera Medical, Inc.®, one of the leading innovator and developer of absorbable surgical adhesives and sealants, has announced the treatment of the first patient in a prospective, multicenter, randomized clinical trial for its lead product,... (Industry News)

All Industry News  Subscribe to Ready-to-Use Adhesives & Sealants Newsletter

This glue news was spotted at News in Adhesives and Sealants Solutions
Get the full story direct from source..